WORLDSymposium™ 2025 Keynote Speakers
Peter Marks, MD, PhD Returns as Keynote Speaker on Thursday, February 6, 2025
WORLDSymposium is excited to announce the return of Peter Marks, MD, PhD, to present a keynote address on Thursday, February 6, 2025. Dr. Marks has been a featured speaker at WORLDSymposium several times in the past 5 years, emphasizing the importance of collaborations between all stakeholders on a global basis including the US FDA, and providing important updates on the FDA’s role in rare disease research.
Dr. Marks is the director of the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA). The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies. Dr. Marks and center staff are committed to facilitating the development of biological products and providing oversight throughout the product life cycle.
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development and is an author or co-author of over 125 publications. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in 2016, and is a Fellow of the American College of Physicians and a member of the National Academy of Medicine.
No one will want to miss Dr. Marks Keynote Address: Advancing the Frontier of Gene Therapy, Thursday, February 6, 2025 at 07:30 PST, at the 21st Annual WORLDSymposium in San Diego, California.